AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 274: H1836-H1840, 1998;
0363-6135/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qin, X.
Right arrow Articles by Tso, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qin, X.
Right arrow Articles by Tso, P.
Vol. 274, Issue 5, H1836-H1840, May 1998

RAPID COMMUNICATION
Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation

Xiaofa Qin, Debi K. Swertfeger, Shuqin Zheng, David Y. Hui, and Patrick Tso

Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0529

Overexpression of apolipoprotein (apo) AIV in transgenic mice confers significant protection against atherosclerosis in apoE knockout animals even in the presence of a more severe atherogenic lipid profile. Because lipoprotein oxidation has been recognized to be pivotal in development of atherosclerosis, the antioxidative activity of apoAIV was investigated. Fasting intestinal lymph was used to mimic conditions in the interstitial fluid, the potential site for lipoprotein oxidation in vivo. ApoAIV (10 µg/ml) significantly inhibited copper-mediated oxidation of lymph. This inhibitory effect was further evaluated using purified low-density lipoprotein. Addition of apoAIV (2.5 µg/ml) increased the time of 50% conjugated diene formation by 2.4-fold, whereas apoE or BSA did not show such a protection even at 20 µg/ml. Addition of apoAIV during the propagation phase also resulted in a dose-dependent inhibition. ApoAIV also protected macrophage-induced oxidation of fasting lymph. These results provide the first evidence that apoAIV is a potent endogenous antioxidant.

antioxidative activity; lipoprotein oxidation; lymph; interstitial fluid; atherosclerosis


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
L. Shelly, L. Royer, T. Sand, H. Jensen, and Y. Luo
Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice
J. Lipid Res., April 1, 2008; 49(4): 773 - 781.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. Levy, K. Trudel, M. Bendayan, E. Seidman, E. Delvin, M. Elchebly, J.-C. Lavoie, L.-P. Precourt, D. Amre, and D. Sinnett
Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats
Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1252 - G1261.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Leng, S. Lu, Y. Yao, Z. Kan, G. S. Morris, B. R. Stair, M. A. Cherny, and D. D. Black
Hepatocyte nuclear factor-4 mediates apolipoprotein A-IV transcriptional regulation by fatty acid in newborn swine enterocytes
Am J Physiol Gastrointest Liver Physiol, August 1, 2007; 293(2): G475 - G483.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. L. Spaulding, F. Saijo, R. H. Turnage, J. S. Alexander, T. Y. Aw, and T. J. Kalogeris
Apolipoprotein A-IV attenuates oxidant-induced apoptosis in mitotic competent, undifferentiated cells by modulating intracellular glutathione redox balance
Am J Physiol Cell Physiol, January 1, 2006; 290(1): C95 - C103.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Lu, Y. Yao, H. Wang, S. Meng, X. Cheng, and D. D. Black
Regulation of apo A-IV transcription by lipid in newborn swine is associated with a promoter DNA-binding protein
Am J Physiol Gastrointest Liver Physiol, February 1, 2003; 284(2): G248 - G254.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Lu, Y. Yao, S. Meng, X. Cheng, and D. D. Black
Overexpression of Apolipoprotein A-IV Enhances Lipid Transport in Newborn Swine Intestinal Epithelial Cells
J. Biol. Chem., August 23, 2002; 277(35): 31929 - 31937.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Kronenberg, E. Kuen, E. Ritz, P. Konig, G. Kraatz, K. Lhotta, J. F. E. Mann, G. A. Muller, U. Neyer, W. Riegel, et al.
Apolipoprotein A-IV Serum Concentrations Are Elevated in Patients with Mild and Moderate Renal Failure
J. Am. Soc. Nephrol., February 1, 2002; 13(2): 461 - 469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Doi, M. Liu, R. J. Seeley, S. C. Woods, and P. Tso
Effect of leptin on intestinal apolipoprotein AIV in response to lipid feeding
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R753 - R759.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. A. Ostos, M. Conconi, L. Vergnes, N. Baroukh, J. Ribalta, J. Girona, J.-M. Caillaud, A. Ochoa, and M. M. Zakin
Antioxidative and Antiatherosclerotic Effects of Human Apolipoprotein A-IV in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 1023 - 1028.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. J. Kalogeris and R. G. Painter
Adaptation of intestinal production of apolipoprotein A-IV during chronic feeding of lipid
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1155 - R1161.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Ishigami, D. K. Swertfeger, M. S. Hui, N. A. Granholm, and D. Y. Hui
Apolipoprotein E Inhibition of Vascular Smooth Muscle Cell Proliferation but Not the Inhibition of Migration Is Mediated Through Activation of Inducible Nitric Oxide Synthase
Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1020 - 1026.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
T. J. Kalogeris, R. G. Painter, and V. R. Holden
Ileal Lipid Infusion Stimulates Jejunal Synthesis of Apolipoprotein A-IV Without Affecting mRNA Levels
Experimental Biology and Medicine, February 1, 2000; 223(2): 198 - 202.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Stein, O. Stein, N. Duverger, G. Halperin, Y. Dabach, G. Hollander, and M. Ben-Naim
Clearance of Cationized LDL Cholesterol From a Muscle Depot Is Not Enhanced in Human Apolipoprotein A-IV Transgenic Mice
Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 179 - 184.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. J. Kalogeris, V. R. Holden, and P. Tso
Stimulation of jejunal synthesis of apolipoprotein A-IV by ileal lipid infusion is blocked by vagotomy
Am J Physiol Gastrointest Liver Physiol, November 1, 1999; 277(5): G1081 - G1087.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. Bridges, H. W. Davis, M. Damodarasamy, Y. Kuroki, G. Howles, D. Y. Hui, and F. X. McCormack
Pulmonary Surfactant Proteins A and D Are Potent Endogenous Inhibitors of Lipid Peroxidation and Oxidative Cellular Injury
J. Biol. Chem., December 1, 2000; 275(49): 38848 - 38855.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online